I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table1_Access to medicines for rare diseases: A European re..:
Noa Rosenberg
;
Sibren van den Berg
;
Nina N. Stolwijk
...
doi:10.3389/fphar.2023.1142351.s001. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1142351.s001
RT Journal T1
Table1_Access to medicines for rare diseases: A European regulatory roadmap for academia.DOCX
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_22188526&Exemplar=1&LAN=DE A1 Noa Rosenberg A1 Sibren van den Berg A1 Nina N. Stolwijk A1 Bart A. W. Jacobs A1 Hendrika C. Post A1 Anna M. G. Pasmooij A1 Saco J. de Visser A1 Carla E. M. Hollak YR 2023 K1 Pharmacology K1 Basic Pharmacology K1 Clinical Pharmacology and Therapeutics K1 Clinical Pharmacy and Pharmacy Practice K1 Pharmaceutical Sciences K1 Pharmacogenomics K1 Toxicology (incl. Clinical Toxicology) K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified K1 regulatory framework K1 patient access K1 marketing authorization K1 alternative drug-to-market routes K1 rare diseases K1 orphan drugs JF doi:10.3389/fphar.2023.1142351.s001 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1142351.s001 DO https://doi.org/10.3389/fphar.2023.1142351.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)